Home Healthcare Biotechnology Autoimmune Disease Diagnostics Market

Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report By Product Type (Instruments, Assay Kits & Consumables), By Disease Type (Systemic Autoimmune Diseases), By Technology (Immunoassays, Indirect Immunofluorescence, Multiplex Assays, Molecular Diagnostics, Point-of-Care Testing, Other Technology), By End User (Hospitals & Clinics, Clinical Laboratories, Academic & Research Institutes, Other End Users) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: April 07, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Autoimmune Disease Diagnostics Market, By Product Type 2022-2034 (USD MILLION/ Units)
    1. Instruments
    2. Assay Kits & Consumables
  2. Autoimmune Disease Diagnostics Market, By Disease Type 2022-2034 (USD MILLION/ Units)
    1. Systemic Autoimmune Diseases
      1. Rheumatoid Arthritis
      2. S2 Systemic Lupus Erythematosus
      3. Scleroderma
      4. Vasculitis
      5. Inflammatory Bowel Disease
      6. Other Diseases
      7. Type 1 Diabetes
      8. Autoimmune Thyroid Diseases
  3. Autoimmune Disease Diagnostics Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Immunoassays
    2. Indirect Immunofluorescence
    3. Multiplex Assays
    4. Molecular Diagnostics
    5. Point-of-Care Testing
    6. Other Technology
  4. Autoimmune Disease Diagnostics Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Hospitals & Clinics
    2. Clinical Laboratories
    3. Academic & Research Institutes
    4. Other End Users
  5. Regional Autoimmune Disease Diagnostics Market
    1. North America
      1. North America Autoimmune Disease Diagnostics Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay Kits & Consumables
      2. North America Autoimmune Disease Diagnostics Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
      3. North America Autoimmune Disease Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassays
        2. Indirect Immunofluorescence
        3. Multiplex Assays
        4. Molecular Diagnostics
        5. Point-of-Care Testing
        6. Other Technology
      4. North America Autoimmune Disease Diagnostics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Clinical Laboratories
        3. Academic & Research Institutes
        4. Other End Users
      5. U.S.
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      6. Canada
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
    2. Europe
      1. Europe Autoimmune Disease Diagnostics Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay Kits & Consumables
      2. Europe Autoimmune Disease Diagnostics Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
      3. Europe Autoimmune Disease Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassays
        2. Indirect Immunofluorescence
        3. Multiplex Assays
        4. Molecular Diagnostics
        5. Point-of-Care Testing
        6. Other Technology
      4. Europe Autoimmune Disease Diagnostics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Clinical Laboratories
        3. Academic & Research Institutes
        4. Other End Users
      5. U.K.
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      6. Germany
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      7. France
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      8. Spain
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      9. Italy
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      10. Russia
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      11. Nordic
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      12. Benelux
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      13. Rest of Europe
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
    3. APAC
      1. APAC Autoimmune Disease Diagnostics Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay Kits & Consumables
      2. APAC Autoimmune Disease Diagnostics Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
      3. APAC Autoimmune Disease Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassays
        2. Indirect Immunofluorescence
        3. Multiplex Assays
        4. Molecular Diagnostics
        5. Point-of-Care Testing
        6. Other Technology
      4. APAC Autoimmune Disease Diagnostics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Clinical Laboratories
        3. Academic & Research Institutes
        4. Other End Users
      5. China
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      6. Korea
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      7. Japan
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      8. India
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      9. Australia
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      10. Taiwan
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      11. South East Asia
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      12. Rest of Asia-Pacific
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
    4. Middle East and Africa
      1. Middle East and Africa Autoimmune Disease Diagnostics Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay Kits & Consumables
      2. Middle East and Africa Autoimmune Disease Diagnostics Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
      3. Middle East and Africa Autoimmune Disease Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassays
        2. Indirect Immunofluorescence
        3. Multiplex Assays
        4. Molecular Diagnostics
        5. Point-of-Care Testing
        6. Other Technology
      4. Middle East and Africa Autoimmune Disease Diagnostics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Clinical Laboratories
        3. Academic & Research Institutes
        4. Other End Users
      5. UAE
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      6. Turkey
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      7. Saudi Arabia
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      8. South Africa
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      9. Egypt
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      10. Nigeria
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      11. Rest of MEA
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
    5. LATAM
      1. LATAM Autoimmune Disease Diagnostics Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay Kits & Consumables
      2. LATAM Autoimmune Disease Diagnostics Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
      3. LATAM Autoimmune Disease Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassays
        2. Indirect Immunofluorescence
        3. Multiplex Assays
        4. Molecular Diagnostics
        5. Point-of-Care Testing
        6. Other Technology
      4. LATAM Autoimmune Disease Diagnostics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Clinical Laboratories
        3. Academic & Research Institutes
        4. Other End Users
      5. Brazil
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      6. Mexico
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      7. Argentina
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      8. Chile
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      9. Colombia
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      10. Rest of LATAM
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.